1. Home
  2. ZURA vs SOTK Comparison

ZURA vs SOTK Comparison

Compare ZURA & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • SOTK
  • Stock Information
  • Founded
  • ZURA 2022
  • SOTK 1975
  • Country
  • ZURA United States
  • SOTK United States
  • Employees
  • ZURA N/A
  • SOTK N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • SOTK Industrial Machinery/Components
  • Sector
  • ZURA Health Care
  • SOTK Technology
  • Exchange
  • ZURA Nasdaq
  • SOTK Nasdaq
  • Market Cap
  • ZURA 69.9M
  • SOTK 58.5M
  • IPO Year
  • ZURA N/A
  • SOTK 1987
  • Fundamental
  • Price
  • ZURA $1.31
  • SOTK $3.66
  • Analyst Decision
  • ZURA Buy
  • SOTK Hold
  • Analyst Count
  • ZURA 7
  • SOTK 1
  • Target Price
  • ZURA $14.33
  • SOTK N/A
  • AVG Volume (30 Days)
  • ZURA 708.2K
  • SOTK 4.9K
  • Earning Date
  • ZURA 08-08-2025
  • SOTK 07-10-2025
  • Dividend Yield
  • ZURA N/A
  • SOTK N/A
  • EPS Growth
  • ZURA N/A
  • SOTK N/A
  • EPS
  • ZURA N/A
  • SOTK 0.09
  • Revenue
  • ZURA N/A
  • SOTK $20,606,116.00
  • Revenue This Year
  • ZURA N/A
  • SOTK N/A
  • Revenue Next Year
  • ZURA N/A
  • SOTK $9.53
  • P/E Ratio
  • ZURA N/A
  • SOTK $40.89
  • Revenue Growth
  • ZURA N/A
  • SOTK N/A
  • 52 Week Low
  • ZURA $0.97
  • SOTK $3.50
  • 52 Week High
  • ZURA $5.07
  • SOTK $6.05
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 59.63
  • SOTK 50.01
  • Support Level
  • ZURA $1.00
  • SOTK $3.63
  • Resistance Level
  • ZURA $1.45
  • SOTK $3.78
  • Average True Range (ATR)
  • ZURA 0.10
  • SOTK 0.13
  • MACD
  • ZURA 0.03
  • SOTK 0.00
  • Stochastic Oscillator
  • ZURA 68.89
  • SOTK 52.38

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

Share on Social Networks: